HLLY:NYSEHolley Inc. Analysis
Data as of 2026-05-19 - not real-time
$2.67
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Holley Inc. (HLLY) is trading at $2.67, well below its 52‑week high of $4.48 and the analyst consensus target of $4.25, indicating a sizable upside potential. The stock sits beneath its 20‑day SMA of $3.03 and 50‑day SMA of $3.06, reinforcing a bearish price trend. Technical momentum is weak, with an RSI of 38.7 and a MACD histogram turning negative, suggesting continued downside pressure. Volatility is extreme at 78% over the past 30 days, and a beta of 1.65 points to amplified moves relative to the market. On the balance sheet, the company carries a debt‑to‑equity ratio of 128% and negative free cash flow, raising solvency concerns. However, the forward PE of 6.85 and a price‑to‑book of 0.71 signal that the equity may be priced attractively relative to fundamentals.
Recent Q1 commentary noted temporary headwinds from elevated distributor inventories and harsh winter weather, but management reported improving order trends toward the second quarter. Revenue contracted 3.7% year‑over‑year, yet operating margins remain above 12% and gross margins near 43%, showing operational resilience. The company’s low price‑to‑sales multiple of 0.53 and a “Buy” consensus from six analysts further support a value case. The lack of dividend payout eliminates yield expectations, but the strong brand portfolio and new car‑care line could unlock incremental revenue. Given the high sector cyclicality and the company’s leverage, downside risk remains material, especially if demand fails to rebound. Overall, the stock presents a classic undervalued, high‑beta play that may reward patient investors who can tolerate short‑term volatility.
Recent Q1 commentary noted temporary headwinds from elevated distributor inventories and harsh winter weather, but management reported improving order trends toward the second quarter. Revenue contracted 3.7% year‑over‑year, yet operating margins remain above 12% and gross margins near 43%, showing operational resilience. The company’s low price‑to‑sales multiple of 0.53 and a “Buy” consensus from six analysts further support a value case. The lack of dividend payout eliminates yield expectations, but the strong brand portfolio and new car‑care line could unlock incremental revenue. Given the high sector cyclicality and the company’s leverage, downside risk remains material, especially if demand fails to rebound. Overall, the stock presents a classic undervalued, high‑beta play that may reward patient investors who can tolerate short‑term volatility.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish MACD and RSI below 40
- Price near technical support at $2.51
- High volatility and beta amplifying downside
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued valuation multiples (PE, PB, P/S)
- Improving order trends reported by management
- Analyst consensus “Buy” with upside potential
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Strong brand portfolio and new product launches
- Elevated debt levels and negative free cash flow
- Cyclical exposure to automotive aftermarket demand
Key Metrics & Analysis
Financial Health
Revenue Growth-3.70%
Profit Margin3.89%
P/E Ratio13.3
ROE5.36%
ROA4.52%
Debt/Equity128.07
P/B Ratio0.7
Op. Cash Flow$51.2M
Free Cash Flow$-5882625
Technical Analysis
TrendBearish
RSI38.7
Support$2.51
Resistance$3.43
MA 20$3.03
MA 50$3.06
MA 200$3.52
MACDBearish
VolumeIncreasing
Fear & Greed Index89.61
Valuation
Target Price$4.67
Upside/Downside74.78%
GradeUndervalued
TypeValue
Risk Assessment
Beta1.65
Volatility78.33%
Sector RiskHigh
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.